Tag: Hives
FDA Approves Dupixent for Chronic Spontaneous Urticaria
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatment
Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
Remibrutinib results in significant improvement in composite measure of itching and hives at week 12 after second-generation H1-antihistamine treatment
ACAAI: Gene-Editing Therapy Reduces Angioedema Attacks in Hereditary Angioedema
Reduction of 75 and 77 percent seen in estimated mean monthly attack rate with 25-mg, 50-mg NTLA-2002 versus placebo
Acupuncture Offers Some Benefit in Chronic Spontaneous Urticaria
However, differences between acupuncture and sham acupuncture, wait-list control did not meet threshold for minimal clinically important difference
Ligelizumab Safely, Effectively Treats Hives
Doses of 72 mg or 240 mg tied to complete control of symptoms after 12-week trial
Omalizumab Effective for Chronic Spontaneous Urticaria
In small study, 85 percent of refractory CSU patients had complete response; rest had well-controlled dx
Review: Lower Cognitive Scores for HIV+, HIV-Exposed Children
Lower scores for HIV+, HIV-exposed uninfected children versus HIV-unexposed and uninfected
CRP Levels Potentially Useful in Chronic Spontaneous Urticaria
Elevated levels appear clinically relevant in patients with condition
Considerable Humanistic Impact for Chronic Spontaneous Urticaria
Two-thirds of patients with CSU report angioedema, which significantly affects health-related QoL
ASST Combined With Other Tests Best IDs Autoimmune Urticaria
ASST combined with all specific parameters has sensitivity of 97 percent, specificity of 86 percent
